Mouse sensitization as an independent risk factor for asthma morbidity
Annals of Allergy, Asthma & Immunology
March Volume 108, Issue 3, Pages 135-140 CME Review
Participants will be able to demonstrate increased knowledge of the clinical treatment of allergy/asthma/immunology and how new information can be applied to their own practices
Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Terri Michele Moncrief, MD (Sr. Author)
Robert S. Kahn, MD, MPH (Author)
Amal Assa’ad, MD (Author)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief
Physicians involved in providing patient care in the field of allergy/asthma/immunology
At the conclusion of this activity, participants should be able to:
● Recognize the prevalence of mouse allergen exposure and sensitization, and identify the diagnostic methods for determining sensitization.
● Identify patients at highest risk for mouse allergen exposure and sensitization, and discuss the potential association with worsened asthma morbidity
Terri Moncrief, MD; Robert Kahn, MD; and Amal Assa’ad, MD
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance